Dr. Motamed, emphasized that this year marks the centennial celebration of Razi Institute, underscoring its longstanding legacy and influence within the region.

Dr. Motamed pointed out that Razi has been a pioneer in antivenom production, leading efforts to identify and develop effective treatments for venomous snakes and scorpions in Iran. The dedicated scientists at the institute have been instrumental in safeguarding the population from the dangers posed by snake and scorpion bites.

Highlighting the significance of the conference, Dr. Motamed stated that Razi's antivenoms are not only recognized and used in Iran but also across the region and internationally, playing a crucial role in saving lives, especially in the Middle East.

In her address, she also announced the introduction of Razi's latest product—a heptavalent antivenom designed to combat a newly identified species of venomous snake originally native to Pakistan, now found in the Sistan and Baluchestan region. This snake previously had no available antivenom, but Razi researchers have successfully developed an effective treatment that is now ready for use.

Regarding the conference details, Dr. Motamed noted that this scientific gathering coincided with Razi Institute's 100th-anniversary celebrations and is supported by the World Health Organization (WHO). The conference was held online via Zoom on Monday and Tuesday, February 17 and 18, from 9 AM to 4 PM. It featured lectures from scientists around the globe, offering a platform for the exchange of cutting-edge scientific findings and fostering international collaboration in the fields of venomous animals and antivenoms.